-
Je něco špatně v tomto záznamu ?
Quantification of paracetamol and 5-oxoproline in serum by capillary electrophoresis: Implication for clinical toxicology
T. Hložek, T. Křížek, P. Tůma, M. Bursová, P. Coufal, R. Čabala,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- acidóza MeSH
- elektroforéza kapilární * MeSH
- kyselina pyrrolidonkarboxylová MeSH
- lidé MeSH
- neopioidní analgetika MeSH
- paracetamol MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
High anion gap metabolic acidosis frequently complicates acute paracetamol overdose and is generally attributed to lactic acidosis or compromised hepatic function. However, metabolic acidosis can also be caused by organic acid 5-oxoproline (pyroglutamic acid). Paracetamol's toxic intermediate, N-acetyl-p-benzoquinoneimine irreversibly binds to glutathione and its depletion leads to subsequent disruption of the gamma glutamyl cycle and an excessive 5-oxoproline generation. This is undoubtedly an underdiagnosed condition because measurement of serum 5-oxoproline level is not readily available. A simple, cost effective, and fast capillary electrophoresis method with diode array detection (DAD) for simultaneous measurement of both paracetamol (acetaminophen) and 5-oxoproline in serum was developed and validated. This method is highly suitable for clinical toxicology laboratory diagnostic, allowing rapid quantification of acidosis inducing organic acid 5-oxoproline present in cases of paracetamol overdose. The calibration dependence of the method was proved to be linear in the range of 1.3-250μgmL-1, with adequate accuracy (96.4-107.8%) and precision (12.3%). LOQ equaled 1.3μgmL-1for paracetamol and 4.9μgmL-1for 5-oxoproline.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010383
- 003
- CZ-PrNML
- 005
- 20180404142007.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jpba.2017.07.024 $2 doi
- 035 __
- $a (PubMed)28797958
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hložek, Tomáš $u Charles University and General University Hospital, First Faculty of Medicine, Institute of Forensic Medicine and Toxicology, Ke Karlovu 2, 121 08, Prague 2, Czech Republic; Charles University, Faculty of Science, Department of Analytical Chemistry, Albertov 6, 128 43, Prague 2, Czech Republic.
- 245 10
- $a Quantification of paracetamol and 5-oxoproline in serum by capillary electrophoresis: Implication for clinical toxicology / $c T. Hložek, T. Křížek, P. Tůma, M. Bursová, P. Coufal, R. Čabala,
- 520 9_
- $a High anion gap metabolic acidosis frequently complicates acute paracetamol overdose and is generally attributed to lactic acidosis or compromised hepatic function. However, metabolic acidosis can also be caused by organic acid 5-oxoproline (pyroglutamic acid). Paracetamol's toxic intermediate, N-acetyl-p-benzoquinoneimine irreversibly binds to glutathione and its depletion leads to subsequent disruption of the gamma glutamyl cycle and an excessive 5-oxoproline generation. This is undoubtedly an underdiagnosed condition because measurement of serum 5-oxoproline level is not readily available. A simple, cost effective, and fast capillary electrophoresis method with diode array detection (DAD) for simultaneous measurement of both paracetamol (acetaminophen) and 5-oxoproline in serum was developed and validated. This method is highly suitable for clinical toxicology laboratory diagnostic, allowing rapid quantification of acidosis inducing organic acid 5-oxoproline present in cases of paracetamol overdose. The calibration dependence of the method was proved to be linear in the range of 1.3-250μgmL-1, with adequate accuracy (96.4-107.8%) and precision (12.3%). LOQ equaled 1.3μgmL-1for paracetamol and 4.9μgmL-1for 5-oxoproline.
- 650 _2
- $a paracetamol $7 D000082
- 650 _2
- $a acidóza $7 D000138
- 650 _2
- $a neopioidní analgetika $7 D018712
- 650 12
- $a elektroforéza kapilární $7 D019075
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kyselina pyrrolidonkarboxylová $7 D011761
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Křížek, Tomáš $u Charles University, Faculty of Science, Department of Analytical Chemistry, Albertov 6, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Tůma, Petr $u Charles University, Third Faculty of Medicine, Department of Biochemistry, Cell and Molecular Biology, Ruská 87, 100 00, Prague 10, Czech Republic.
- 700 1_
- $a Bursová, Miroslava $u Charles University and General University Hospital, First Faculty of Medicine, Institute of Forensic Medicine and Toxicology, Ke Karlovu 2, 121 08, Prague 2, Czech Republic; Charles University, Faculty of Science, Department of Analytical Chemistry, Albertov 6, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Coufal, Pavel $u Charles University, Faculty of Science, Department of Analytical Chemistry, Albertov 6, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Čabala, Radomír $u Charles University and General University Hospital, First Faculty of Medicine, Institute of Forensic Medicine and Toxicology, Ke Karlovu 2, 121 08, Prague 2, Czech Republic; Charles University, Faculty of Science, Department of Analytical Chemistry, Albertov 6, 128 43, Prague 2, Czech Republic. Electronic address: radomir.cabala@vfn.cz.
- 773 0_
- $w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 145, č. - (2017), s. 616-620
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28797958 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142047 $b ABA008
- 999 __
- $a ok $b bmc $g 1287868 $s 1007195
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 145 $c - $d 616-620 $e 20170726 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
- LZP __
- $a Pubmed-20180404